recent high impact publications
- Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).
Heidel* FH, De Stefano V, Zaiss M, Kisro J, Gückel E, Großer S, Zuurman MW, Manz K, Bryan K, Afsharinejad A, Griesshammer M, Kiladjian JJ
Leukemia 2025, 39(7), 1692-701 * corresponding author - p53 reveals principles of chromatin remodeling and enhancer activation.
Fischer M, Schwarz* R, Riege* K, Förste S, Schwab K, Wiechens E, van Bömmel A, Hoffmann S
Nucleic Acids Res 2025, 53(11) * equal contribution - Aging and diet alter the protein ubiquitylation landscape in the mouse brain.
Marino* A, Di Fraia* D, Panfilova D, Sahu AK, Minetti A, Omrani O, Cirri E, Ori A
Nat Commun 2025, 16(1), 5266 * equal contribution - The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.
Kühn MWM, Pemmaraju N, Heidel FH
Leukemia 2025 (epub ahead of print) - Embryonic macrophages orchestrate niche cell homeostasis for the establishment of the definitive hematopoietic stem cell pool.
Perçin** G, Riege K, Fröbel J, Metz J, Culemann S, Lesche M, Reinhardt S, Höfer T, Hoffmann S, Waskow** C
Nat Commun 2025, 16(1), 4428 ** co-corresponding authors - Emerging roles of transfer RNA fragments in the CNS.
Winek** K, Soreq** H
Brain 2025 (epub ahead of print) ** co-corresponding authors
